How do I communicate ultrasound findings of questionable mild increased liver echotexture (possibly indicative of hepatic steatosis), a benign hepatic cyst, and a nonspecific hyperechoic structure near the umbilicus (possibly a periumbilical fat-containing hernia) to a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Communicating Ultrasound Findings to Your Patient

Your patient has three findings on ultrasound: mildly increased liver brightness suggesting fatty liver (a common and usually manageable condition), a benign liver cyst that requires no treatment, and a possible small hernia near the belly button that may need further evaluation only if causing symptoms.

Breaking Down Each Finding

1. Mildly Increased Liver Echotexture (Possible Fatty Liver)

This finding suggests fatty infiltration of the liver, which is extremely common and typically related to metabolic factors. 1

  • Explain that the liver appears slightly brighter than normal on ultrasound, which often indicates fat accumulation in liver cells 1
  • Emphasize that ultrasound has limited sensitivity for mild steatosis and this is a subjective finding with inter-observer variability 2
  • Reassure that this is frequently seen in patients with metabolic conditions like diabetes, obesity, elevated cholesterol, or high blood pressure 2

Next steps for fatty liver evaluation:

  • Obtain comprehensive liver function tests (ALT, AST, alkaline phosphatase, bilirubin) to assess actual liver health 2
  • Screen for metabolic risk factors including diabetes, blood pressure, and lipid panel 2
  • Calculate a non-invasive fibrosis score (FIB-4 or NAFLD Fibrosis Score) to determine if there's any scarring risk 2
  • If two or more metabolic risk factors are present, more thorough evaluation is warranted as progression risk increases 2

Management approach:

  • Address underlying metabolic conditions through lifestyle modifications (weight loss, exercise, dietary changes) 2
  • Optimize control of diabetes, hypertension, and cholesterol if present 2
  • For simple steatosis with low fibrosis risk, repeat liver tests and assessment in 6-12 months is typically sufficient 2

2. Benign Hepatic Cyst

This is a simple fluid-filled sac in the liver that is completely benign and requires no treatment or follow-up. 1

  • Explain that simple liver cysts are extremely common, occurring in 15-18% of the population 3, 4
  • Emphasize these are congenital (present from birth) and follow an indolent course without significant changes over time 1
  • No follow-up imaging is recommended for asymptomatic simple hepatic cysts regardless of size 1
  • Reassure that these cysts do not become cancerous and do not affect liver function 1
  • Only if symptoms develop (abdominal pain, early satiety, compression symptoms) would repeat ultrasound be indicated 1

3. Hyperechoic Structure Near Umbilicus (Possible Periumbilical Hernia)

This finding likely represents a small fat-containing hernia near your belly button, which is common and usually not concerning unless it causes symptoms.

  • Explain that the ultrasound detected a bright area near the umbilicus that may be fat protruding through a small weakness in the abdominal wall
  • Periumbilical hernias are common and often contain fat tissue
  • The radiologist suggests follow-up CT only "if clinically indicated" - meaning only if you have symptoms

When to pursue CT imaging:

  • If the patient experiences pain, tenderness, or a palpable bulge at the umbilicus
  • If there are signs of incarceration (trapped tissue) such as persistent pain, nausea, or inability to reduce a bulge
  • If the patient is symptomatic and considering surgical repair, CT would help surgical planning
  • If completely asymptomatic with no palpable abnormality on physical exam, observation alone is reasonable

Key Reassurance Points

  • The liver finding is mild and manageable through lifestyle and metabolic optimization 2
  • The liver cyst is benign and needs no intervention 1
  • The possible hernia only needs further evaluation if causing symptoms
  • None of these findings suggest serious or malignant disease

Follow-Up Plan

For the liver findings:

  • Blood work to assess liver function and metabolic parameters 2
  • Lifestyle counseling regarding diet, exercise, and weight management 2
  • Repeat assessment in 6-12 months if low risk 2

For the cyst:

  • No follow-up needed 1

For the periumbilical finding:

  • Physical examination to assess for palpable hernia
  • CT only if symptomatic or if physical exam confirms a hernia requiring surgical evaluation
  • Otherwise, reassurance and observation

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Slightly Echogenic Hepatic Parenchyma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An updated review of cystic hepatic lesions.

Clinical and experimental hepatology, 2019

Related Questions

What is the possible diagnosis for a 31-year-old patient with normal thyroid gland but signs of focal hepatic steatosis in the liver?
Can multiple small hepatic cysts, largest 2 centimeters in size, cause right upper quadrant (RUQ) pain?
What is the recommended management for a patient with hepatic steatosis, atelectasis, and a small right fissural lymph node?
What is the management approach for a 40-year-old patient with a complex septated left hepatic cyst on ultrasound, mild elevation of liver function tests, normal total bilirubin (t bili) and normal alkaline phosphatase (alp), and no other significant past medical history?
A male patient who was 13 years old in 2017 had a hepatic cyst that grew from about 78 mm height (54 × 24 mm) to roughly 112 × 73 mm by 2021, now presents in 2025 with leukocytosis (~13 ×10⁹/L) and is tapering psychotropic medications (Atryline stopped, Zexil 50 mg daily, Preziva dose reduced, Neuroplex reduced to twice daily). What is the clinical significance of the cyst growth, leukocytosis, and medication taper, and what diagnostic steps should be taken next?
What is the diagnostic approach and initial treatment for pericarditis?
What is the diagnosis and treatment for a patient with primary hypothyroidism, elevated TSH, low T3, and high T4?
Is gabapentin and a neurology referral reasonable for sudden onset facial numbness?
Can the Tdap (tetanus, diphtheria, and pertussis) vaccine be given to a patient 2 weeks after the last Skyrizi (risankizumab) injection?
What is the initial management for patients with heart failure with preserved ejection fraction?
Can Shingrix (recombinant zoster vaccine) be administered to patients on Skyrizi (risankizumab)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.